Jennifer Cusiter (PhD MBA)
Head of CMVM Research & Innovation Operations
Address
- Street
-
College of Medicine and Veterinary Medicine
College Office, Second floor, Neighbourhood K
Usher Building, The University of Edinburgh
5‒7 Little France Road, Edinburgh BioQuarter Gate 3 - City
- Edinburgh
- Post code
- EH16 4UX
Background
Jenny has a PhD in Bioorganic Chemistry from WESTChem at the University of Glasgow, an MBA from the Open University and an MSci in Pure and Applied Chemistry from the University of Strathclyde. She previously worked as an Analyst for Evolution Life Sciences preparing market research reports for the Life Sciences and Healthcare sectors. She has extensive experience in evaluating novel technologies including therapeutics, medical devices and diagnostics.
She was initially employed at the University of Edinburgh from January 2010 as an Enterprise Associate with the University of Edinburgh Entrepreneur in Residence team. She was recruited into the BioQuarter Business Development team during June 2010 with a remit to commercialise intellectual property from NHS Lothian. Latterly her BioQuarter role focused on commercialisation of IP from the Centre for Regenerative Medicine. Her next role was as UK Regenerative Medicine Platform Hub Project Manager. The UKRMP Engineered Cell Environment Hub was based at the MRC Centre for Regenerative Medicine at the University of Edinburgh. Her remit was to co-ordinate and grow this major UK-wide multi-partner project to address the technical and scientific challenges associated with translating promising scientific discoveries towards clinical impact.
She is currently Head of CMVM Research & Innovation Operations and helps support the CMVM Dean of Research and Dean of Innovation. The team play a major strategic role in developing CMVM research, supporting staff and ensuring that the College strategy and environment support the highest levels of research excellence and integrity. She helps support priority areas for College wide coordination of our research portfolio development including translation, innovation and commercialisation; clinical trials; global health; open research; research culture.